Overall, we believe that the identification of the SNHG1/DNMT3A/miR-129-2-5p/Rac1 effector pathway that plays a major role in driving bladder cancer stemness and invasion may help develop a new therapeutic approach to treat this difficult disease. Here, RAC1 is linked to urinary bladder carcinoma.